With better understanding of the COPD inflammatory mechanisms, broad spectrum anti-inflammatory drugs may be more effective, such as inhibitors of PDE4, p38 MAPK and NF-κB, some data suggest that anti-inflammatory therapies might provide a way to prevent COPD condition worsens (Barnes, 2008). The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.